Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Not yet recruiting Phase 2 Interventional

Safety, Tolerability and Efficacy of RGH-202 in Social Anxiety Disorder (STAGE)

ClinicalTrials.gov ID: NCT07931703

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT07931703. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 19, 2026, 8:29 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2a, Multicenter, Randomized, Double-blind, Two-arm, Placebo-controlled Clinical Trial to Assess the Safety, Tolerability and Efficacy of RGH-202 for the Management of Performance and Social Interaction Anxiety in Adults With Social Anxiety Disorder

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The reason for this trial is to see if the investigational product, called RGH-202, is safe and well tolerated, and can help people with social anxiety disorder. The main questions this study aims to answer are: * Is RGH-202 safe and well tolerated in adults with social anxiety disorder? * Does RGH-202 reduce symptoms of social anxiety disorder compared with placebo? RGH-202 will be compared with a placebo (a product that does not contain any active ingredients) to determine whether the investigational medicine may be an effective treatment for SAD. Participants will have an equal chance of receiving RGH-202 or the placebo taken for 6 weeks. Participants will attend regular clinic visits for safety assessments, study evaluations and complete questionnaires related to their social anxiety symptoms.

Study identification

NCT ID
NCT07931703
Recruitment status
Not yet recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Gedeon Richter Plc.
Industry
Enrollment
156 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 12, 2026 (Estimated)
Primary completion
Feb 13, 2028 (Estimated)
Completion
Feb 13, 2028 (Estimated)
Last update posted
Nov 12, 2026

2026 – 2028

United States locations

U.S. sites
7
U.S. states
6
U.S. cities
7
Facility City State ZIP Site status
Leading Edge Research LA, LLC Encino California 91316 —
Clinical Neuroscience Solutions, LLC Jacksonville Florida 32256 —
Clinical Neuroscience Solutions, LLC Orlando Florida 32801 —
Redbird Research LLC. Las Vegas Nevada 89119 —
Integrative Clinical Trials, LLC Brooklyn New York 11229 —
New Hope Clinical Research Inc. Charlotte North Carolina 28211 —
Clinical Neuroscience Solutions, LLC Memphis Tennessee 38119 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07931703, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 12, 2026 · Synced Nov 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.